Document Detail


Zygomycosis in Immunocompromised non-Haematological Patients.
MedLine Citation:
PMID:  21625316     Owner:  NLM     Status:  PubMed-not-MEDLINE    
Abstract/OtherAbstract:
Zygomycoses caused by fungi of the mucorales order (mucormycoses) are emerging fungal diseases with a high fatality rate. The most important risk factors include neutropenia or functional neutropenia, diabetic ketoacidosis, iron overload, major trauma, prolonged use of corticosteroids, illicit intravenous drug (ID) use, neonatal prematurity, malnourishment, and maybe a previous exposure to antifungal agents with no activity against zygomycetes, such as voriconazole and echinocandins.A high index of suspicion is crucial for the diagnosis, as prompt and appropriate management can considerably reduce morbidity and mortality. Suspicion index can be increased through recognition of the differential patterns of clinical presentation. In the non- haematological immunocompromised patients, mucormycosis can manifest in various clinical forms, depending on the underlying condition: mostly as rhino-orbital or rhino-cerebral in diabetes patients, pulmonary infection in patients with malignancy or solid organ transplantation, disseminated infection in iron overloaded or deferoxamine treated patients, cerebral - with no sinus involvement - in ID users, gastrointestinal in premature infants or malnourishment, and cutaneous after direct inoculation in immunocompetent individuals with trauma or burns.Treating a patient's underlying medical condition and reducing immunosuppression are essential to therapy. Rapid correction of metabolic abnormalities is mandatory in cases such as uncontrolled diabetes, and corticosteroids or other immunosuppressive drugs should be discontinued where feasible. AmphotericinB or its newer and less toxic lipid formulations are the drugs of choice regarding antifungal chemotherapy, while extensive surgical debridement is essential to reduce infected and necrotic tissue. A high number of cases could be prevented through measures including diabetes control programmes and proper pre- and post-surgical hygiene.
Authors:
George Petrikkos; Miranda Drogari-Apiranthitou
Related Documents :
14570866 - Serum insulin concentrations in daily drinkers compared with abstainers in the new mexi...
12479986 - Prevalence of anxiety in adults with diabetes: a systematic review.
7211996 - Senile lens changes and diabetes in two population studies.
9015676 - Ethnic differences in diabetes care in a multiethnic community in new zealand.
15546686 - Ciprofloxacin at low levels disrupts colonization resistance of human fecal microflora ...
7040596 - Effects of ammonia on liver lysosomal functionality in salmo gairdneri rich.
Publication Detail:
Type:  Journal Article     Date:  2011-03-15
Journal Detail:
Title:  Mediterranean journal of hematology and infectious diseases     Volume:  3     ISSN:  2035-3006     ISO Abbreviation:  Mediterr J Hematol Infect Dis     Publication Date:  2011  
Date Detail:
Created Date:  2011-05-31     Completed Date:  2011-07-14     Revised Date:  2011-07-28    
Medline Journal Info:
Nlm Unique ID:  101530512     Medline TA:  Mediterr J Hematol Infect Dis     Country:  Italy    
Other Details:
Languages:  eng     Pagination:  e2011012     Citation Subset:  -    
Affiliation:
4st Dept. of Internal Medicine, School of Medicine, National and Kapodistrian University of Athens, "ATTIKON" Hospital, RIMINI 1 - Haidari, Athens - 12464. Greece.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  5-azacytidine in chronic myelomonocytic leukemia: case report and review of literature.
Next Document:  Invasive Candida infections in patients with haematological malignancies and hematopoietic stem cell...